|
Administering Lutetium-177-PSMA-617 (PLUVICTO) Clinical Trials
1 actively recruiting trial across 1 location
Houston, Texas1 trial
Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617
Excel Diagnostics & Nuclear Oncology Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.